Shield Therapeutics PLC Holding(s) in Company (4170J)

TIDMSTX TIDMSTXW

RNS Number : 4170J

Shield Therapeutics PLC

28 June 2017

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                     SHIELD THERAPEUTICS PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
------------------------------------------------------  --------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                          ü 
-------------------------------------------------------  -------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-------------------------------------------------------  -------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
-------------------------------------------------------  -------------------------------- 
 An event changing the breakdown of voting rights                     ü 
-------------------------------------------------------  -------------------------------- 
 Other (please 
  specify): 
-----------------------------------------------------    -------------------------------- 
 3. Full name of person(s)                                                   W. HEALTH LP 
  subject to the 
  notification obligation: 
  (iii) 
------------------------------------------------------  --------------------------------- 
 4. Full name of shareholder(s)                           HARGREAVE HALE NOMINEES LIMITED 
  (if different from 3.):(iv) 
------------------------------------------------------  --------------------------------- 
 5. Date of the transaction                                              28(th) JUNE 2017 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
------------------------------------------------------  --------------------------------- 
 6. Date on which issuer                                                 28(th) JUNE 2017 
  notified: 
------------------------------------------------------  --------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                                           49% to 48% 
------------------------------------------------------  --------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                  Resulting situation after the 
  of              to the triggering                   triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ----------------------------------  ------------------------------------------------------------------ 
                 Number            Number            Number          Number of                % of voting 
                  of                of                of shares       voting                   rights (x) 
                  Shares            Voting                            rights 
                                    Rights 
--------------  ----------------  ----------------  --------------  -----------------------  ------------------------- 
                                                     Direct          Direct     Indirect      Direct        Indirect 
                                                                     (xi)        (xii) 
--------------      ------------    ------------    --------------  ---------  ------------  ------------  ----------- 
 
  GB00BYV81293   54,062,901        54,062,901        56,008,541                 56,008,541                  48.24% 
                ----------------  ----------------  --------------  ---------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration      Exercise/                         Number of voting           % of voting 
  instrument          date            Conversion                        rights that                rights 
                      (xiii)          Period (xiv)                      may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
------------------  --------------  --------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise        Expiration      Exercise/         Number of voting           % of voting 
 financial          price          date            Conversion         rights instrument          rights (xix, 
 instrument                        (xvii)          period             refers to                  xx) 
                                                   (xviii) 
----------------  --------------  --------------  ----------------  -------------------------  ----------------------- 
                                                                                                Nominal       Delta 
----------------  --------------  --------------  ----------------  -------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                               Percentage of voting rights 
----------------------------------------------------  ---------------------------------------------------------------- 
 56,008,541                                            48.24% 
----------------------------------------------------  ---------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
------------------------------------------------------------------------------------ 
 
                                      Shares held by Hargreave Hale Nominees Limited 
 
 Proxy Voting: 
------------------------------------------------------------------------------------ 
 10. Name of the proxy holder:                            N/A 
-------------------------------------------------------  --------------------------- 
 11. Number of voting rights proxy                        N/A 
  holder will cease to hold: 
-------------------------------------------------------  --------------------------- 
 12. Date on which proxy holder will                      N/A 
  cease to hold voting rights: 
-------------------------------------------------------  --------------------------- 
 
 
  13. Additional information: 
-------------------------------------------------------  --------------------------- 
 14. Contact name:                                        Matthew Edwards (on behalf 
                                                           of W. Health L.P.) 
-------------------------------------------------------  --------------------------- 
 15. Contact telephone number:                            0203 620 2000 
-------------------------------------------------------  --------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLFPMLTMBJTMJR

(END) Dow Jones Newswires

June 28, 2017 05:37 ET (09:37 GMT)